Study title: Single dose methodology pilot study comparing the safety and efficacy of naproxen, ibuprofen and placebo in treatment of pain secondary to dental impaction surgery
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Anesthesia and Analgesia | |||||
Brands: | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: NAPROXEN | |||||
ATC code: | |||||
Document link: Bayer CC_Naproxen Sodium_CC-01519_study_synopsis.pdf | |||||
Document date: 2011-09-15 | |||||
Study number: CC-01519 | |||||
EudraCT number: | |||||
Scope of study: | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |